Croydon, Surrey-based RDi, a provider of healthcare and pharma services for patient sample collection, has appointed David Cahill as chief executive.

Cahill has more than 25 years’ experience in healthcare, life sciences and the pharma industry. He was previously chief commercial and strategy officer for diagnostics provider Alliance Medical, where he led partnership delivery to private and NHS customers.

RDi’s chairman Martin Hiscox said “[Cahill] brings with him many years of experience in healthcare alongside a proven track record of leadership and proposition development. With RDi innovating the remote self-sampling market, David is well placed to drive us on to the next phase in our ambitions.”

Chris Tagg, chief strategy officer at RDi, added: “David has fantastic diagnostics experience which coupled with his proven success at driving expansion and growth see him coming on board to lead RDi at a pivotal time.

“We have been on a journey that has seen us drive the business into the emerging virtual healthcare sector and having David’s knowledge, capabilities and support will be a major asset in enabling us to complete that journey.”

Cahill commented: “RDi has proven large-volume solutions already in the marketplace changing the way that patients can provide samples for screening and diagnostics. I have been hugely excited by the potential to further transform access to healthcare for patients through areas such as clinical trials and screening. There is a great deal of potential for RDi and its innovative products. I am looking forward to working with the amazing team and our clients to support and expedite the solutions that are currently in such demand.”